Peapack Gladstone Financial Corp Novartis Ag Transaction History
Peapack Gladstone Financial Corp
- $7.07 Billion
- Q2 2025
A detailed history of Peapack Gladstone Financial Corp transactions in Novartis Ag stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 22,497 shares of NVS stock, worth $2.96 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
22,497
Previous 20,309
10.77%
Holding current value
$2.96 Million
Previous $2.26 Million
20.23%
% of portfolio
0.04%
Previous 0.03%
Shares
33 transactions
Others Institutions Holding NVS
# of Institutions
1,563Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.4 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.37 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.19 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$996 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$939 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...